Transition report pursuant to Rule 13a-10 or 15d-10

Document and Entity Information

v3.21.1
Document and Entity Information - USD ($)
9 Months Ended
Dec. 31, 2020
Mar. 15, 2021
Jun. 30, 2020
Cover [Abstract]      
Entity Registrant Name Qualigen Therapeutics, Inc.    
Entity Central Index Key 0001460702    
Document Type 10-KT    
Document Transition Report true    
Document Period End Date Dec. 31, 2020    
Amendment Flag false    
Current Fiscal Year End Date --03-31    
Entity Well-Known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business Flag true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Entity Shell Company false    
Entity Public Float     $ 45,357,020
Entity Common Stock, Shares Outstanding   28,780,714  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2020